Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

60.70
Delayed Data
As of May 27
 +0.76 / +1.27%
Today’s Change
47.36
Today|||52-Week Range
68.75
+5.55%
Year-to-Date

Today’s Trading

Previous close59.94
Today’s open60.00
Day’s range59.92 - 60.75
Volume3,227,382
Average volume (3 months)5,651,551
Market cap$57.5B
Dividend yield2.22%
Data as of 05/27/2015

Growth & Valuation

Earnings growth (last year)+139.61%
Earnings growth (this year)+2.38%
Earnings growth (next 5 years)+0.70%
Revenue growth (last year)-0.47%
P/E ratio18.9
Price/Sales2.42
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc+0.29+1.41%
VBLTVascular Biogenics L...-0.05-0.68%
NEPTNeptune Technologies...+0.04+2.94%
Data as of 05/27/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)$1.29
Annual revenue (last year)$20.3B
Annual profit (last year)$3.1B
Net profit margin15.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers